News

News Medical on MSN5d
Blocking chemokine receptor increases effectiveness of glucocorticoids in multiple myeloma treatment
Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment responses in multiple myeloma patients by blocking a protein that plays a key ...
Hosted on MSN24d
TBX2 protein acts as a switch to drive prostate cancer treatment resistance, study finds
Their study, "A TBX2-Driven Signaling Switch from Androgen Receptor to Glucocorticoid Receptor Confers Therapeutic Resistance in Prostate Cancer," which was published in December 2024 by Oncogene ...
EurekAlert!25d
Study focuses on resistance to androgen receptor-targeted therapy in advanced prostate cancer
Their study (“A TBX2-Driven Signaling Switch from Androgen Receptor to Glucocorticoid Receptor Confers Therapeutic Resistance in Prostate Cancer”), which was published in December 2024 by ...